NMN Complex
NMN Complex, licence 80140861: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- CIMKIZ GROUP INC.
- NPN or DIN-HM
- 80140861
- Status
- Active licence
- Licence date
- 12 May 2025
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3-(Aminocarbonyl)-1-(5-O-phosphonato-bêta -D-ribofuranosyl)pyridinium | 300.0 mg | Not calculated |
| Pyrus communis Source : Pyrus communis - fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 300 mg | 60.0 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 50.0 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 50.0 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 mg | 50.0 mg | Not calculated |
| Biotine Source : Biotine | 125.0 Microgrammes | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 30.0 mg | Not calculated |
| Acide hyaluronique Source : Gallus gallus - Crête | 30.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism/(and) tissue formation. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which is an important cofactor in energy metabolism. Supports biological functions which play a key role in the maintenance of good health. Helps to maintain/support the body's ability to metabolize nutrients. Helps to maintain and/or support cardiovascular health. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80140861
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.